X hits on this document

PDF document

Common Congenital Heart Lesions - page 90 / 126





90 / 126

90 of 126

  • A.


    • Mechanism of action: reduce volume causing reduced preload. End - diastolic volume and pressure fall, preventing pulmonary congestion.

    • If patient is on the flat part of the Frank-Starling curve, then decrease in preload will not significantly reduce CO. Must monitor dosage carefully to ensure diuretic does NOT significantly CO.

    • Only used if there is evidence of pulmonary congestion (rales) or edema

    • Since patients with heart failure have reduced renal perfusion, they must be treated with LOOP diuretics (furosemide, torsemide, bumetanide), thiazide diuretics can also be used

    • Caution: overdiuresis decreases CO and causes hypokalemia and hypomagnesia, which can precipitate arrhythmias.

    • If patient has purely diastolic dysfunction, then they need high diastolic filling pressures, therefore must be careful with diuretics

  • B.


    • Mechanism of action: counteract vasoconstriction of neurohormonal mechanisms, results in reduced volume and ventricular remodeling

    • Venous vasodilators (nitrates): decrease venous return to the heart, reducing LV diastolic filling pressure and pulmonary capillary hydrostatic pressure, results in decreased pulmonary congestion

    • Arteriolar vasodilators (hydralazine): decrease systemic vascular resistance, therefore decreases afterload and increases SV. Increased CO balances decreased TPR, causing BP to stay the same.

    • Balanced vasodilators (ACE inhibitors): affects both veins and arteries. ACE inhibitors reduce AII, which 1. reduces vasoconstriction 2. reduces aldosterone promoting sodium and water excretion and decreasing volume 3. increases bradykinin, a vasodilator

      • 4.

        limits ventricular remodeling

    • ACE inhibitors increase survival and are the standard first line therapy for patients with LV systolic dysfunction.

    • What if patient can’t tolerate ACE inhibitors? Angiotensin II receptor blockers (ARB) also block AII and do not cause cough associated with ACE Inhibitors. Can also use H-ISDN (combo of venous dilator isosorbide dinitrate and arteriolar dilator hydralazine). Third choice is Nesiritide (recombinant BNP), but administered IV and is expensive.

Document info
Document views447
Page views447
Page last viewedSat Jan 21 15:34:59 UTC 2017